Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1038-2018

Drug recall · August 15, 2018

Valsartan/HCTZ 160/25mg Tablets recall

Why: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,

Lots / codes

Lot # T11443; Exp. 02/28/2019

Quantity
N/A
Company
NuCare Pharmaceuticals Inc, Orange, CA
Distribution
Distributed to three customers in Fl and CA
Initiated
July 30, 2018 · Voluntary: Firm initiated
Classified
August 3, 2018
Reported
August 15, 2018
Ended
April 22, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Valsartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.